Sign Out
Finasteride is an Azasteroid that inhibits the type-2 isoform of 5±-reductase, the enzyme responsible for conversion of testosterone to the more active dihydrotestosterone, and therefore has anti-androgenic properties. It is given orally in a dose of 5 mg daily in the management of benign prostatic hyperplasia to cause regression of the enlarged prostate and to improve symptoms; it may reduce the incidence of acute urinary retention and the need for surgery. Response may be delayed and treatment may be required for 6 months or more to assess whether benefit has been achieved. In the treatment of male-pattern baldness (alopecia androgenetica) in men, Finasteride is given orally in a dose of 1 mg daily. In general, use for 3 months or more is required before benefit is seen, and effects are reversed within 12 months of ceasing therapy.
Or as prescribed by the physician.
Continue with Google